breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal new junction evidence (lowest skew 10 of 42 shown) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NC_000913 | = 4534139 | 260 (1.010) | 10 (0.040) | 4/258 | NT | 3.9% | intergenic (‑86/+291) | yjhX/yjhZ | UPF0386 family protein/pseudogene, rimK paralog, C‑terminal fragment |
? | NC_000913 | = 4534160 | 254 (1.060) | intergenic (‑107/+270) | yjhX/yjhZ | UPF0386 family protein/pseudogene, rimK paralog, C‑terminal fragment | |||||
* | ? | NC_000913 | 4407335 = | 297 (1.150) | 7 (0.030) | 3/268 | NT | 2.4% | coding (682/2442 nt) | rnr | exoribonuclease R, RNase R |
? | NC_000913 | 4407371 = | 284 (1.140) | coding (718/2442 nt) | rnr | exoribonuclease R, RNase R | |||||
* | ? | NC_000913 | = 4372705 | 264 (1.020) | 3 (0.010) | 3/262 | NT | 1.1% | intergenic (+34/‑104) | groL/yjeI | Cpn60 chaperonin GroEL, large subunit of GroESL/DUF4156 family lipoprotein |
? | NC_000913 | = 4372719 | 271 (1.120) | intergenic (+48/‑90) | groL/yjeI | Cpn60 chaperonin GroEL, large subunit of GroESL/DUF4156 family lipoprotein | |||||
* | ? | NC_000913 | 3998038 = | 283 (1.100) | 12 (0.050) | 4/264 | NT | 4.7% | coding (56/2163 nt) | uvrD | DNA‑dependent ATPase I and helicase II |
? | NC_000913 | 3998077 = | 215 (0.880) | coding (95/2163 nt) | uvrD | DNA‑dependent ATPase I and helicase II | |||||
* | ? | NC_000913 | = 3986661 | 243 (0.940) | 9 (0.040) | 4/262 | NT | 3.7% | intergenic (+23/+25) | glmZ/hemY | sRNA antisense activator of glmS mRNA, Hfq‑dependent/putative protoheme IX synthesis protein |
? | NC_000913 | = 3986667 | 237 (0.980) | intergenic (+29/+19) | glmZ/hemY | sRNA antisense activator of glmS mRNA, Hfq‑dependent/putative protoheme IX synthesis protein | |||||
* | ? | NC_000913 | = 3931793 | 261 (1.010) | 3 (0.010) | 3/262 | NT | 1.2% | coding (478/1869 nt) | kup | potassium transporter |
? | NC_000913 | = 3931842 | 250 (1.030) | coding (527/1869 nt) | kup | potassium transporter | |||||
* | ? | NC_000913 | 3925258 = | 335 (1.300) | 3 (0.010) | 3/266 | NT | 0.96% | coding (376/1890 nt) | mnmG | 5‑methylaminomethyl‑2‑thiouridine modification at tRNA U34 |
? | NC_000913 | 3925292 = | 301 (1.220) | coding (342/1890 nt) | mnmG | 5‑methylaminomethyl‑2‑thiouridine modification at tRNA U34 | |||||
* | ? | NC_000913 | = 3795026 | 250 (0.970) | 3 (0.010) | 3/262 | NT | 1.2% | coding (98/1047 nt) | waaF | ADP‑heptose:LPS heptosyltransferase II |
? | NC_000913 | = 3795059 | 244 (1.010) | coding (131/1047 nt) | waaF | ADP‑heptose:LPS heptosyltransferase II | |||||
* | ? | NC_000913 | = 3700159 | 211 (0.820) | 4 (0.020) | 3/266 | NT | 1.7% | noncoding (24/66 nt) | rdlD | sRNA antisense regulator affects LdrD translation; proposed addiction module in LDR‑D repeat, with toxic peptide LdrD |
? | NC_000913 | = 3700189 | 250 (1.010) | noncoding (54/66 nt) | rdlD | sRNA antisense regulator affects LdrD translation; proposed addiction module in LDR‑D repeat, with toxic peptide LdrD | |||||
* | ? | NC_000913 | = 3660236 | 256 (0.990) | 6 (0.020) | 3/270 | NT | 2.3% | coding (1005/1158 nt) | mdtE | anaerobic multidrug efflux transporter, ArcA‑regulated |
? | NC_000913 | = 3660280 | 259 (1.040) | coding (1049/1158 nt) | mdtE | anaerobic multidrug efflux transporter, ArcA‑regulated |